Improvement of toxic epidermal necrolysis after the early administration of a single high dose of intravenous immunoglobulin
- 31 July 2003
- journal article
- case report
- Published by Elsevier in Annals of Allergy, Asthma & Immunology
- Vol. 91 (1) , 86-91
- https://doi.org/10.1016/s1081-1206(10)62065-0
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Delayed reactions to drugs show levels of perforin, granzyme B, and Fas-L to be related to disease severityJournal of Allergy and Clinical Immunology, 2002
- Treatment of drug-induced toxic epidermal necrolysis (Lyell's syndrome) with intravenous human immunoglobulinsBurns, 2001
- Anticonvulsant-induced toxic epidermal necrolysis: Monitoring the immunologic responseJournal of Allergy and Clinical Immunology, 2000
- A case of toxic epidermal necrolysis treated with intravenous immunoglobulinBritish Journal of Dermatology, 2000
- Randomised comparison of thalidomide versus placebo in toxic epidermal necrolysisThe Lancet, 1998
- Inhibition of Toxic Epidermal Necrolysis by Blockade of CD95 with Human Intravenous ImmunoglobulinScience, 1998
- Toxic epidermal necrolysisThe Lancet, 1998
- Severe Adverse Cutaneous Reactions to DrugsNew England Journal of Medicine, 1994
- T-cell subsets in drug-induced toxic epidermal necrolysis. Possible pathogenic mechanism induced by CD8-positive T cellsArchives of Dermatology, 1991
- The culprit drugs in 87 cases of toxic epidermal necrolysis (Lyell's syndrome)Archives of Dermatology, 1987